Adolor Provides Regulatory Update on Entereg(R) (alvimopan) - MSN MoneyCentral
Adolor Corporation ADLR announced today that the U.S. Food and Drug Administration (FDA) has communicated to the company that it will not be issuing an action letter on the NDA for Entereg(R) (alvi...